Method for preparing anti-esophageal cancer medicine by polarizing macrophages into M1 subtype in co-culture microenvironment by human embryonic stem cells

By inducing macrophages to M1 subtype using human embryonic stem cell conditioned culture medium in co-culture microenvironment, the problem of M1 type macrophage induction in the prior art was solved, and effective inhibition of esophageal cancer cells was achieved, and the Potential in anti-esophageal cancer treatment.

CN119082025APending Publication Date: 2024-12-06CHONGQING MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411378610.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-30
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art is difficult to effectively induce M1 type macrophages, and their biological toxicity cannot be directly applied to the human body, which limits its application in the treatment of anti-esophageal cancer.

Method used

In the co-culture microenvironment, macrophages are stimulated using human embryonic stem cell conditioned culture medium, and the macrophages are induced to polarize to the M1 subtype by binding of appropriate proportions of human embryonic stem cell conditioned culture medium and complete culture medium of macrophages, thereby induced macrophages to polarize to the M1 subtype. Prepare antiesophageal cancer drugs.

Benefits of technology

Successfully induced M1 macrophages can significantly inhibit the proliferation, migration and invasion of esophageal cancer cells, promote their apoptosis, and show potential to become a new anti-esophageal cancer biotherapeutic drug.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082025A_ABST
    Figure CN119082025A_ABST
Patent Text Reader

Abstract

The invention provides a method for preparing an anti-esophageal cancer drug by polarizing macrophages into M1 subtypes in a co-culture microenvironment through human embryonic stem cells. The human embryonic stem cells are typical pluripotent stem cells which are highly undifferentiated, and a new strategy can be provided for biological treatment of tumors. The macrophage M1 subtype can promote inflammation and perform immunostimulation, and shows certain potential in tumor immunotherapy. After the human embryonic stem cell condition culture solution is used for culturing the macrophages, the macrophages are stimulated by the human embryonic stem cell microenvironment to be polarized towards the macrophages M1 subtype and secrete'anti-esophageal cancer factors' into the microenvironment, and then the esophageal cancer cells are cultured by the macrophages M1 subtype conditions, so that the esophageal cancer cells are obtained. The anti-esophageal cancer effect of the macrophage M1 subtype in a tumor microenvironment is simulated. The macrophage M1 subtype stimulated by the human embryonic stem cell conditioned culture solution has a certain inhibition effect on proliferation, migration and invasion of esophageal cancer cells, which indicates that the macrophage M1 subtype has the potential to become a novel anti-esophageal cancer biological treatment drug.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of biomedicine, and in particular relates to a method for preparing M1 macrophages and an application thereof in preparing an anti-esophageal cancer drug. Background Art

[0002] Macrophages are a diverse group of white blood cells whose main function is to phagocytose and eliminate pathogens. M0 cells are differentiated from monocytes induced by macrophage colony stimulating factor (M-CSF). M0 macrophages will form M1 macrophages after activation by LPS and Th1 cytokines (such as INF-γ and TNF-α), and will form M2 macrophages under the activation of IL4, IL13, IL10, IL33 and TGF-β. Among them, the surface markers of M1 macrophages include TLR2, TLR4, CD80, CD86, INOS and MHC-Ⅱ. In order to induce macrophage polarization to M1, PMA was added to THP-1 to stimulate differentiation into macrophages, and LPS and IFN-γ were added to stimulate its differentiation into M1 macrophages. However, this induction method cannot be directly applied to the body due to the biological toxicity of the inducer. Therapy that revitalizes the body's own immune system to target tumor cells has brought remarkable results for many types of cancer. Interestingly, administering embryonic stem cells to mice can stimulate the secretion of Th1 cytokines. In the early stages of tumor development, administering embryonic stem cells can more effectively stimulate the immune system to produce more lymphocytes and cytokines. Increasing the proportion of lymphocytes and normalizing the secretion of cytokines can help reverse existing immune dysfunction and rebuild the host's anti-tumor immunity.

[0003] Cancer is the result of abnormal differentiation and unlimited proliferation of normal tissue cells in the body. It is usually without capsule and unclear boundaries. It has the characteristics of invading and metastasizing to surrounding tissues and even the whole body. It has become one of the most common causes of death. Esophageal cancer is a digestive tract tumor with the highest incidence and mortality rate in the world. Esophageal squamous cell carcinoma is one of the most common esophageal malignancies, originating from abnormal proliferation of esophageal squamous epithelium. Due to the lack of obvious early clinical symptoms of esophageal squamous cell carcinoma, most cases are usually diagnosed in the late stage.

[0004] The occurrence and development of esophageal cancer is a complex biological process with the combined effects of multiple genes, multiple factors, multiple stages and multiple steps. The treatment of esophageal cancer is mainly based on surgery combined with radiotherapy and chemotherapy. The occurrence and development of individual tumors depends not only on the tumorigenic activity of tumor cells, but also on the immune characteristics of the body. In the era of immunotherapy, it is crucial to explore the relevant molecular events in the tumor immune microenvironment, and the role of immune cells in esophageal cancer has also received increasing attention. Studies have reported that immune cells in the tumor microenvironment (TME) can participate in the host's immune surveillance and tumor killing under certain conditions. Among them, macrophages are a double-edged sword with potential pro-cancer and anti-cancer effects. Pro-inflammatory type 1 (M1 macrophages) can inhibit the occurrence, development, metastasis and drug resistance of solid tumors including esophageal cancer, while anti-inflammatory type 2 (M2 macrophages) play the opposite pro-cancer role. In different tumor microenvironments, the M1 subtype of macrophages plays different or even opposite functions. In esophageal squamous cell carcinoma, the density of the M1 subtype of macrophages is negatively correlated with the patient's lymph node metastasis, clinical stage and tumor infiltration depth, and the increase in the density of the M1 subtype of macrophages is positively correlated with a good prognosis of esophageal squamous cell carcinoma, indicating that the M1 macrophage subtype can be used as a good prognostic factor for patients with esophageal cancer. Increasing the proportion of M1 macrophages in the TME is a promising therapeutic strategy. Summary of the invention

[0005] In order to solve the problems in the prior art, the object of the present invention is to provide a method for preparing an anti-esophageal cancer drug by polarizing macrophages into M1 subtype in a co-culture microenvironment using human embryonic stem cells.

[0006] The inventor unexpectedly discovered that after culturing macrophages with human embryonic stem cell conditioned medium, the macrophages will be stimulated by the human embryonic stem cell microenvironment, polarize to the macrophage M1 subtype, and secrete "anti-esophageal cancer factors" into the microenvironment. The study found that using a suitable ratio of human embryonic stem cell conditioned medium to stimulate a suitable ratio of macrophages in the culture system can fully stimulate the macrophages to polarize to the M1 subtype, thereby achieving anti-tumor properties.

[0007] Unless otherwise specified, the parts described in the present invention are all parts by weight and the percentages described are all mass percentages.

[0008] To achieve the above object, the technical solution of the present invention is:

[0009] A method for preparing an anti-esophageal cancer drug by polarizing macrophages to M1 subtype using human embryonic stem cells in a co-culture microenvironment, characterized in that it comprises the following steps:

[0010] (1) Pre-laying human pluripotent stem cells on a base of matrix gel to prepare a special culture plate for human embryonic stem cells;

[0011] (2) using the human embryonic stem cell culture plate pre-coated in step (1) to perform human embryonic stem cell recovery and inoculation;

[0012] (3) Human embryonic stem cells are passaged;

[0013] (4) using the human pluripotent stem cells pre-plated in step (1) to form a culture plate specifically for human embryonic stem cells for inoculation of human embryonic stem cells;

[0014] (5) Collection of human embryonic stem cell conditioned medium;

[0015] (6) Human monocytic leukemia cells induced into human macrophages;

[0016] (7) Cultivating macrophages with human embryonic stem cell conditioned medium. Collect and filter the human embryonic stem cell conditioned medium, discard the macrophage supernatant, and culture the macrophages in a ratio of human embryonic stem cell conditioned medium: human macrophage complete medium = 1:1. Place the macrophages in a 37° C., 5% CO2 incubator for culture.

[0017] (8) Collect the supernatant after 24h-72h of conditioned macrophage culture.

[0018] The present invention uses a specific stem cell culture medium during the stimulation of human embryonic stem cells to keep the human embryonic stem cells in an undifferentiated state as much as possible.

[0019] The human embryonic stem cells described in the present invention are established stem cell lines.

[0020] The human pluripotent stem cell-based matrix gel comprises hESC-QualifiedMatrix (Cat. No.: 354277). The culture medium includes PGM1 human pluripotent stem cell culture medium (Beijing Saibei Biotechnology, Cat. No.: 1007500).

[0021] The human embryonic stem cell conditioned medium for stimulating macrophage M1 subtype is preferably a human embryonic stem cell conditioned medium obtained by culturing human embryonic stem cells in an appropriate proportion.

[0022] The method for pre-laying a special culture plate for human embryonic stem cells is to dilute the matrix gel and then pre-lay the culture plate, and place it in a 37° C. constant temperature, 5% CO 2 incubator for 4 hours.

[0023] The matrix gel was diluted with DPBS, One or two of the hESC-Qualified Matrix were diluted according to the ratio of matrix gel to diluent of 1:5-1:9.

[0024] The method for resuscitation of human embryonic stem cells is to rinse the special culture plate coated with matrix gel in advance with DPBS twice, add 1mL / well human pluripotent stem cell complete culture medium, and place it in a 37°C constant temperature, 5% CO2 incubator for preheating; take a 15mL centrifuge tube, add 1mL human pluripotent stem cell complete culture medium for use; take out the human embryonic stem cells from liquid nitrogen, and place them in a 37°C constant temperature water bath to melt; transfer the cell suspension to a 15mL centrifuge tube containing 1mL human pluripotent stem cell complete culture medium, centrifuge (5min, 1000rpm / min), after the centrifugation is completed, discard the supernatant, add 1mL human pluripotent stem cell complete culture medium to resuspend the cells into cell clusters, and evenly inoculate them in the culture plate coated with preheated matrix gel, and change the medium every day.

[0025] The human embryonic stem cell digestion and passage method is to rinse the special culture plate coated with matrix gel in advance with DPBS twice, add 1mL / well human pluripotent stem cell complete medium, and place it in a 37°C constant temperature, 5% CO2 incubator for pre-warming; take human embryonic stem cells in the logarithmic growth period, discard the waste liquid, add DPBS to rinse twice, then add human pluripotent stem cell digestion solution, and transfer to a 37°C constant temperature, 5% CO2 incubator for digestion for 5-7min. Under the microscope, it can be seen that the cell colony gap is obvious and shiny and round, then the digestion solution can be discarded, and then human pluripotent stem cell complete medium is added, and the cell colony is gently blown off in a fan shape to form a cell mass composed of 3-8 cells, and the blown cell suspension is evenly inoculated into the culture plate coated with matrix gel pre-warmed.

[0026] When selecting embryonic stem cells for subculture, cell clones with a density of 80%-90%, round and dense, and smooth edges are selected.

[0027] The method for collecting the human embryonic stem cell conditioned culture medium is to take human embryonic stem cells in the logarithmic growth phase, observe that the cell fusion degree reaches 60%, collect the culture medium, centrifuge at 4°C, 3000rpm*10min, collect the supernatant and filter it with a 0.22μm microporous filter membrane, and transfer the filtrate to a -80°C refrigerator for storage after packaging.

[0028] The inducing factors of human macrophages include one or two of Phorbol 12-myristate 13-acetate (MCE, catalog number: 16561-29-8), IFN-gamma, Human (MCE, catalog number: HY-P7025), LPS (Sigma, catalog number: L2630), and human embryonic stem cell conditioned medium.

[0029] The method for inducing human monocytic leukemia cells to become human macrophage M1 subtype is to take human monocytic leukemia cells in the logarithmic growth phase, add 100ng / mL concentration of Phorbol 12-myristate 13-acetate to the culture medium, transfer the culture plate to a 37°C constant temperature, 5% CO2 incubator for incubation for 24h-48h, that is, human macrophages, and cells can be seen to grow in clusters by adhering to the wall under a microscope. After the human macrophages are successfully induced, the M1 polarized subtype is induced, macrophages are cultured with human embryonic stem cell conditioned medium, the collected and filtered human embryonic stem cell conditioned medium is taken, the macrophage supernatant is discarded, and macrophages are cultured according to human embryonic stem cell conditioned medium: human macrophage complete medium = 1:1, and placed in a 37°C constant temperature, 5% CO2 incubator for 24h-72h, that is, human macrophage M1 subtype, and cells can be seen to be ameba-like and have pseudopodia extending under a microscope. IFN-gamma, Human at a concentration of 20 ng / mL and LPS at a concentration of 100 ng / mL were added to the human macrophage culture medium for induction, and the macrophage culture plate was transferred to a 37°C constant temperature, 5% CO2 incubator and incubated for 24h-72h to obtain the human macrophage M1 subtype.

[0030] The method for collecting macrophage M1 subtype conditioned medium is as follows: after culturing macrophages with human embryonic stem cell conditioned medium for 24h-72h, the medium is updated to fresh medium, placed in a 37°C constant temperature, 5% CO2 incubator for 24h, the conditioned medium is collected with a centrifuge tube, centrifuged at 4°C, 3000rpm*10min, the supernatant is collected and filtered with a 0.22μm microporous filter membrane, and the filtrate is transferred to a -80°C refrigerator for storage after packaging.

[0031] Beneficial Effects

[0032] Human embryonic stem cells are a typical highly undifferentiated pluripotent stem cell that is isolated from the inner cell mass of the blastocyst stage and the primordial germ cells of the early embryo and have developmental omnipotence. Proinflammatory type 1 (M1 macrophages) can inhibit the occurrence, development, metastasis and drug resistance of solid tumors including esophageal cancer, and play a certain anti-tumor immune role in the treatment of various tumors. The inventor unexpectedly discovered that after culturing macrophages with human embryonic stem cell conditioned medium, the macrophages will be stimulated by the microenvironment of human embryonic stem cells, polarize to the M1 subtype of macrophages, and play an effective anti-esophageal cancer role. Therefore, the M1 macrophage subtype stimulated by embryonic stem cells in the co-culture microenvironment can be used to treat esophageal cancer.

[0033] The macrophage M1 subtype stimulated by the human embryonic stem cells of the present invention in the co-culture microenvironment achieves a certain inhibitory effect on the proliferation, migration and invasion of esophageal cancer cells, and shows a significant effect in promoting their apoptosis, indicating that it has the potential to become a new biological therapeutic drug against esophageal cancer. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] Figure 1 This is a diagram showing the polarization of macrophages into the M1 subtype stimulated by human embryonic stem cell conditioned medium, specifically the experimental results of detecting the mRNA expression of markers related to the M1 polarization subtype by qRT-PCR;

[0035] Figure 2 Human embryonic stem cell conditioned medium stimulates macrophage polarization to M1 subtype, specifically, the experimental result of detecting the positive rate of M1 polarization subtype related markers by flow cytometry;

[0036] Figure 3 This is a graph showing the results of macrophage M1 subtype conditioned medium inhibiting the proliferation of esophageal cancer cells after stimulation with human embryonic stem cell conditioned medium, specifically the results of the CCK8 experiment;

[0037] Figure 4 This is a diagram showing the results of macrophage M1 subtype inhibiting the proliferation of esophageal cancer cells after stimulation with human embryonic stem cell conditioned medium, specifically a diagram showing the results of a plate clone formation experiment;

[0038] Figure 5 This is a graph showing the results of macrophage M1 subtype inhibiting the proliferation of esophageal cancer cells after stimulation with human embryonic stem cell conditioned medium, specifically a statistical graph of plate clone formation experiment;

[0039] Figure 6 This is a diagram showing the effect of macrophage M1 subtype inhibiting the healing ability of esophageal cancer cells after stimulation with human embryonic stem cell conditioned medium, specifically a diagram showing the results of a scratch experiment;

[0040] Figure 7 This is a diagram showing the inhibitory effect of macrophage M1 subtype on the wound healing ability of esophageal cancer cells after stimulation with human embryonic stem cell conditioned medium, specifically a statistical diagram of the scratch test results;

[0041] Figure 8 This is a diagram showing the effect of macrophage M1 subtype inhibiting the migration of esophageal cancer cells after stimulation with human embryonic stem cell conditioned medium, specifically a diagram showing the results of a Transwell migration experiment;

[0042] Fig. 9 This is a diagram showing the effect of macrophage M1 subtype inhibiting the migration of esophageal cancer cells after stimulation with human embryonic stem cell conditioned medium, specifically a statistical diagram of the results of the Transwell migration experiment;

[0043] Fig.10 This is a diagram showing the effect of macrophage M1 subtype inhibiting the invasion of esophageal cancer cells after stimulation with human embryonic stem cell conditioned medium, specifically a diagram showing the results of the Transwell invasion experiment;

[0044] Fig.11 This is a diagram showing the effect of macrophage M1 subtype inhibiting the invasion of esophageal cancer cells after stimulation with human embryonic stem cell conditioned medium, specifically a statistical diagram of Transwell invasion assay results;

[0045] Fig.12 The M1 subtype of macrophages inhibited the proliferation, migration and invasion of esophageal cancer after stimulation with human embryonic stem cell conditioned medium. Specifically, this figure shows the experimental results of detecting the expression of invasion indicators MMP2 and MMP9 proteins in osteosarcoma cells by Western blotting. DETAILED DESCRIPTION

[0046] The present invention is described in detail below through specific examples. It is pointed out that the following examples are only used to further illustrate the present invention and cannot be understood as limiting the scope of protection of the present invention. Those skilled in the art can make some non-essential improvements and adjustments to the present invention based on the above invention content. The raw materials and reagents used in the present invention are all commercially available products. Among them, the esophageal cancer KYSE150 cell line in the embodiment is purchased from Pronosai Biotechnology Company; the human embryonic stem cell in the embodiment is an established stem cell line, specifically the human embryonic stem cell H9 cell line, purchased from the stem cell bank of the Chinese Academy of Sciences; the human monocytic leukemia cell THP-1 in the embodiment is purchased from Pronosai Biotechnology Company.

[0047] Example 1

[0048] 1. Preparation and Collection of Human Embryonic Stem Cell Conditioned Medium

[0049] Pre-spread human pluripotent stem cell substrate working solution to prepare a special culture plate for human embryonic stem cells: pre-spread 1 mL of diluted human pluripotent stem cell substrate working solution (matrigel: diluent = 1:9) in each well of a 6-well plate with a diameter of 6 cm, and place the 6-well plate in a cell culture incubator at 37°C and 5% CO2 overnight.

[0050] Digestion and passage: The special culture plate coated with matrix gel in advance was rinsed twice with DPBS, and 5 mL of human pluripotent stem cell complete culture medium supplemented with factor TZV (Beijing Saibei Biological, Catalog No.: 3009007) was added to 500 mL of human pluripotent stem cell complete culture medium (Beijing Saibei Biological, Catalog No.: 1007500), and 1 mL / well of the prepared human pluripotent stem cell complete culture medium was added to the special culture plate, and the plate was placed in a 37°C constant temperature, 5% CO2 incubator for preheating; human embryonic stem cells in the logarithmic growth period were taken, the waste liquid was discarded, 1 mL of DPBS was added for rinse twice, and then 1 mL of human pluripotent stem cell digestion solution (Beijing Saibei Biological, Catalog No.: 1023100) was added, and the plates were transferred to a 37°C constant temperature, 5% CO2 incubator for digestion for 5-7 minutes. Under the microscope, the cell colonies were observed to have obvious gaps and were shiny and round. The digestion solution was then discarded. Human pluripotent stem cell complete culture medium was added and the cell colonies were gently blown off in a fan-shaped manner to form cell clusters of 3-8 cells. The cell suspension (5×10 5 ) were evenly inoculated into culture plates pre-warmed with matrix gel.

[0051] Collect human embryonic stem cell conditioned medium: after human embryonic stem cells are digested and subcultured for 48 hours, human embryonic stem cells in the logarithmic growth phase are obtained, and the cell fusion degree is observed to reach 60%, and the culture medium is collected and centrifuged at 4°C, 3000rpm*10min, the supernatant is collected and filtered with a 0.22μm microporous filter membrane, and the filtrate is transferred to a -80°C refrigerator for storage after aliquoting.

[0052] 2. Human embryonic stem cell conditioned medium stimulates macrophage polarization to M1 subtype

[0053] Human monocytic leukemia cells are induced to become human macrophages: human monocytic leukemia cells in the logarithmic growth phase are taken, PMA at a concentration of 100 ng / mL is added to the culture medium, and the culture plate is transferred to a 37°C constant temperature, 5% CO2 incubator for incubation for 24h-48h, which is human macrophages. Under the microscope, cells can be seen to grow in clusters attached to the wall. After the human macrophages are successfully induced, the M1 subtype is induced, and macrophages are cultured with human embryonic stem cell conditioned medium. The collected and filtered human embryonic stem cell conditioned medium is taken, and the macrophage supernatant is discarded. Macrophages are cultured according to the human embryonic stem cell conditioned medium: human macrophage complete medium = 1:1, and placed in a 37°C constant temperature, 5% CO2 incubator for 48h, which is the human macrophage M1 subtype. Under the microscope, the cells are ameba-like and have pseudopodia extending. IFN-gamma, Human at a concentration of 20 ng / mL and LPS at a concentration of 100 ng / mL were added to the human macrophage culture medium for induction. The macrophage culture plate was transferred to a 37°C constant temperature, 5% CO2 incubator for incubation for 48 hours, which is the human macrophage M1 subtype. Cell template RNA was extracted and reverse transcribed into cDNA for qRT-PCR experiments: After designing the primer sequence, DEPC water was used to dilute the upper and lower primers, and the premixed system Mix was prepared. DEPC water, primers, and sybergreen were added in sequence. The mixed solution Mix was added to the eight-tube strip on an ice box, and cDNA was added to each well in turn. The amplification product was detected by amplification curve analysis, GAPDH was used as an internal reference, and all data were analyzed using The results showed that ( Figure 1 ), after macrophages Mφ were stimulated with human embryonic stem cell conditioned medium for 48 hours, the mRNA content levels of M1 subtype-related indicators were significantly increased.

[0054] After macrophages were stimulated with human embryonic stem cell conditioned medium, the expression of macrophage markers was analyzed by flow cytometry. Single-cell suspensions of macrophages were prepared and stained with CD86 PE (Biolegend, Catalog No.: No.305405), CD206 APC (Biolegend, Catalog No.: No.321109) and CD11b FITC (Biolegend, Catalog No.: No.301329) on ice and protected from light. After rinsing with PBS, the ratio of macrophage M1 / M2 was detected by flow cytometry (BD Biosciences, USA). The results showed that ( Figure 2 ) After stimulation with human embryonic stem cell conditioned medium, the positive rate of macrophage M1 marker CD86 was significantly higher than that in the LPS+INF / γ group, while the positive rate of M2 marker CD206 did not increase.

[0055] 3. Preparation and Collection of Macrophage M1 Polarized Subtype Conditioned Medium after Human Embryonic Stem Cell Conditioned Medium Stimulation

[0056] After stimulating macrophages with human embryonic stem cell conditioned medium, it was replaced with fresh medium and cultured in a 37°C constant temperature, 5% CO2 incubator for 24 hours. The conditioned medium was collected in a centrifuge tube and centrifuged at 4°C, 3000rpm*10min. The supernatant was collected and filtered with a 0.22μm microporous filter membrane. After aliquoting, the filtrate was transferred to a -80°C refrigerator for storage.

[0057] Example 2

[0058] Inhibitory effects of macrophage M1 subtype conditioned medium stimulated by human embryonic stem cell conditioned medium on the proliferation, migration and invasion of esophageal cancer cells

[0059] 1. Cell Proliferation Assay

[0060] Take esophageal cancer cells in the logarithmic growth phase and set them at 5*10 3 Cells were seeded in a 96-well plate. 100uL of culture medium was added, containing 20%, 40%, 60%, and 80% concentrations of macrophage M1 subtype conditioned medium. The 96-well plate was placed in a 37°C constant temperature, 5% CO2 incubator. After 48 hours, 10uL of cck8 working solution was added to each well and incubated for 60 minutes. The absorbance of each well at 450nm was detected by a microplate reader. Cell survival rate = (OD of the experimental group - OD of the blank group) / (OD of the control group - OD of the blank group) * 100%. The conditioned medium of the macrophage M1 subtype inhibited the proliferation of esophageal cancer cells as the concentration increased. Subsequent experiments were carried out using the conditioned medium of the macrophage M1 subtype at the same concentration. The results showed that ( Figure 3 ) The conditioned medium of macrophage M1 subtype stimulated by human embryonic stem cell conditioned medium can inhibit the proliferation of esophageal cancer cells in a concentration-dependent manner. Subsequently, 80% volume fraction of conditioned medium was selected for experiments.

[0061] 2. Cell colony formation assay

[0062] Take esophageal cancer cells in the logarithmic growth phase, digest them, centrifuge them, and adjust the cell concentration to a single cell suspension after resuspending. Add 700 single cells to each well of a six-well plate. After 24 hours, wait for the cells to adhere to the wall and replace the culture medium with the conditioned medium of the macrophage M1 subtype (concentration 80%) and the conditioned medium of embryonic stem cells (concentration 80%). Culture for 14 days until clumps of about 50 cell colonies can be seen under the microscope. Aspirate the culture medium, wash twice with PBS buffer, add 4% paraformaldehyde to fix for 20 minutes, add 0.1% crystal violet staining solution to stain for 20 minutes, discard the dye, rinse with running water until the well plate is completely clean, and take a picture. The results show ( Figure 4-5 ), compared with the Control group and hESC CM group, the hESC-MφCM group and Mφ+LPS / IFN-γCM group could inhibit the in vitro clone formation ability of esophageal cancer cells.

[0063] 3. Cell scratch assay

[0064] Take esophageal cancer cells in the logarithmic growth phase, digest them, centrifuge them, and resuspend them into 2mL of esophageal cancer cell suspension. Take a six-well plate, add 2mL of complete culture medium to each well, and evenly inoculate the resuspended cell suspension in each well. Place it in a 37°C constant temperature, 5% CO2 incubator. When the cells grow to a dense state, use a 200uL pipette tip to evenly draw vertical lines in each well. After washing twice with PBS, replace the culture medium with the conditioned medium of the macrophage M1 subtype (concentration 80%) and the conditioned medium of human embryonic stem cells (concentration 80%). Take pictures at 0h and 24h, and count the migration area of ​​esophageal cancer cells. The results show that ( Figure 6-7 ), compared with the Control group and hESC CM group, the hESC-MφCM group and Mφ+LPS / IFN-γCM group could inhibit the wound healing ability of esophageal cancer cells.

[0065] 4. Cell Migration Assay

[0066] Take the esophageal cancer cells in the logarithmic growth phase after starvation for 24 hours, digest and centrifuge them, resuspend the cells in the same concentration of macrophage M1 subtype conditioned medium and embryonic stem cell conditioned medium, and place them in a small chamber for 5*10 4 The cells were inoculated in the upper chamber of the Transwell chamber, and complete medium containing 20% ​​FBS was added to the lower chamber. After 48 hours, the liquid in the upper chamber was aspirated and fixed with 4% paraformaldehyde for 20 minutes, and then stained with 0.1% crystal violet staining solution for 20 minutes. The excess crystal violet solution was washed away with PBS, and the cells were observed and photographed under a microscope, and the cell migration rate was counted. The results showed that ( Figure 8-9 ), compared with the Control group and hESC CM group, the hESC-MφCM group and Mφ+LPS / IFN-γCM group could inhibit the migration ability of esophageal cancer cells.

[0067] 5. Cell invasion assay

[0068] 100uL of matrix gel was pre-coated in the upper chamber and placed in a 37°C constant temperature, 5% CO2 incubator for 4 hours. Esophageal cancer cells in the logarithmic growth phase that had been starved for 24 hours were digested and centrifuged, and the cells were resuspended in the same concentration of macrophage M1 subtype conditioned medium and embryonic stem cell conditioned medium, and 5*10 cells were added to each chamber. 4 The cells were inoculated in the upper chamber of the Transwell chamber containing matrix gel, and complete medium containing 20% ​​FBS was added to the lower chamber. After 48 hours, the liquid in the upper chamber was aspirated and fixed with 4% paraformaldehyde for 20 minutes, and then stained with 0.1% crystal violet staining solution for 20 minutes. The excess crystal violet solution was washed away with PBS, and the cells were observed and photographed under a microscope, and the cell invasion rate was counted. The results showed that ( Figure 10-11), compared with the Control group and hESC CM group, the hESC-MφCM group and Mφ+LPS / IFN-γCM group could inhibit the invasion ability of esophageal cancer cells.

[0069] 6. Western blotting to detect the expression of MMP2 and MMP9 proteins in esophageal cancer cells

[0070] Use 6CM 2 Esophageal cancer cells were cultured in culture dishes. When the cells grew to 60% density, the culture medium was replaced with the conditioned medium of macrophage M1 subtype (80% concentration) and embryonic stem cell conditioned medium (80% concentration). The protein was collected after 48 hours of continuous action. Western blotting experiment: 10% concentration precast gel was used, electrophoresis solution was added to the electrophoresis tank, the sample was loaded after the comb was pulled out, and markers and protein samples of each group were added to the wells. The program was set to constant voltage 80V, 30min; 120V, 80min. The target band was cut according to the molecular weight of the target protein. The target protein band was placed on the transfer clamp according to the "sandwich" clamp method, and the transfer solution was added. The program was set to constant current 250mA, time 45min, 90min. After the transfer, the PVDF membrane was blocked in a rapid blocking solution for 20min, and the primary antibody was incubated at low temperature overnight and the secondary antibody for 2h. The bands were imaged and developed using an enhanced chemiluminescence analysis kit and a luminescent image analyzer. The results showed ( Fig.12 ), compared with the Control group and hESC CM group, the expressions of MMP2 and MMP9 proteins in the hESC-MφCM group and Mφ+LPS / IFN-γCM group were significantly decreased. MMP2 and MMP9 are marker proteins of invasion ability, indicating that the hESC-MφCM group and Mφ+LPS / IFN-γCM group can reduce the invasion ability of esophageal cancer cells.

Claims

1. A method for preparing M1 subtype macrophages, comprising the following steps: Step 1, pre-laying human pluripotent stem cells on a base of matrix gel to prepare a special culture plate for human embryonic stem cells; Step 2, using the human embryonic stem cell culture plate pre-laid in step 1 to culture human embryonic stem cells, collecting the human embryonic stem cell conditioned culture medium and filtering it for later use; Step 3, inducing human monocytic leukemia cells into human macrophages; Step 4: Cultivate macrophages in human embryonic stem cell conditioned medium: prepare the human embryonic stem cell conditioned medium in step 2 in a 1:1 ratio to culture macrophages in a 37°C constant temperature and 5% CO 2 The cells were cultured in an incubator for 24-72 hours and the supernatant was collected after 24-72 hours of conditioned macrophage culture.

2. The method according to claim 1, Its characteristics are also: Human pluripotent stem cells are coated with matrix gel: diluent = 1:5-1:9, and the diluent is added to a culture plate or culture dish with a diameter of 6 cm, and the culture plate is incubated at 37°C and 5% CO 2 The cells were placed in an incubator for 4 hours to prepare a special culture plate for human embryonic stem cells.

3. The method according to claim 2, Its characteristics are also: hESC-QualifiedMatrix (Cat. No.: 354277); the diluent is DPBS.

4. The method according to claims 1 to 3, Its characteristics are also: The method for collecting human embryonic stem cell conditioned culture medium comprises the following steps: taking human embryonic stem cells in the logarithmic growth phase and inoculating them into a special culture plate for human embryonic stem cells, observing that the cell fusion degree reaches 60%, collecting the culture medium, centrifuging at 4°C, 3000rpm*10min, collecting the supernatant and filtering it with a 0.22μm microporous filter membrane, and transferring the filtrate to a -80°C refrigerator for storage after packaging.

5. The method according to claim 1, Its characteristics are also: The inducing factors of human macrophages include one or two of Phorbol12-myristate 13-acetate (Cat. No.: 16561-29-8), IFN-gamma, Human (Cat. No.: HY-P7025), LPS (Cat. No.: L2630), and human embryonic stem cell conditioned medium.

6. The method according to claim 1, Its characteristics are also: The method for inducing human monocytic leukemia cells to become human macrophages is as follows: human monocytic leukemia cells in the logarithmic growth phase are inoculated into a culture plate, RPMI1640 culture medium containing 100 ng / mL of Phorbol 12-myristate 13-acetate is added, and the cells are placed in a 37°C constant temperature, 5% CO2 incubator for incubation for 24h-48h to obtain human macrophages.

7. The method according to claim 1 or 6, Its characteristics are also: To induce the M1 subtype, macrophages were cultured with human embryonic stem cell conditioned medium. The human embryonic stem cell conditioned medium was collected and filtered, and the macrophage supernatant was discarded. The macrophages were cultured in a ratio of human embryonic stem cell conditioned medium to human macrophage complete medium = 1:1, and placed in a constant temperature of 37°C and 5% CO 2 After culturing in the incubator for 24h-72h, the cells become the M1 subtype of human macrophages. Under the microscope, the cells appear amoeboid and have extended pseudopodia.

8. The method according to claim 7, Features: After 24-72 hours of conditioned culture of macrophages, fresh culture medium was used and placed in a constant temperature of 37°C and 5% CO. 2 Culture in an incubator for 24 hours, collect the conditioned medium in a centrifuge tube, centrifuge at 4°C, 3000rpm*10min, collect the supernatant and filter with a 0.22μm microporous filter membrane, and transfer the filtrate to a -80°C refrigerator for storage after aliquoting.

9. Use of human embryonic stem cells prepared by the method of any one of claims 1 to 8 in polarizing macrophages to M1 subtype in a co-culture microenvironment for preparing an anti-esophageal cancer drug.